Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Studies on the xanthine oxidase activity of mammalian cells.

× No keyword cloud information.

27 in total

1. USE OF TRIS(HYDROXYMETHYL)AMINOMETHANE BUFFERS IN CULTURES OF DIPLOID HUMAN FIBROBLASTS.

Authors: G M MARTIN
Journal: Proc Soc Exp Biol Med Date: 1964-05

2. A PERSISTENT STRAIN OF DIPLOID FIBROBLASTS.

Authors: R S KROOTH; M W SHAW; B K CAMPBELL
Journal: J Natl Cancer Inst Date: 1964-05 Impact factor: 13.506

3. PROPERTIES ODF DIPLOID CELL STRAINS DEVELOPED FROM PATIENTS WITH AN INHERITED ABNORMALITY OF URIDINE BIOSYNTHESIS.

Authors: R S KROOTH
Journal: Cold Spring Harb Symp Quant Biol Date: 1964

4. The xanthine oxidase activity of rat tissues.

Authors: W W WESTERFELD; D A RICHERT
Journal: Proc Soc Exp Biol Med Date: 1949-06

5. Multiple differentiated functions in an unusual clonal strain of hepatoma cells.

Authors: A H Tashjian; F C Bancroft; U I Richardson; M B Goldlust; F A Rommel; P Ofner
Journal: In Vitro Date: 1970 Jul-Aug

Review 6. Regulation of gene expression in somatic cell hybrids: a review.

Authors: R L Davidson
Journal: In Vitro Date: 1971 May-Jun

7. Expression of differentiated functions in hepatoma cell hybrids: reappearance of tyrosine aminotransferase inducibility after the loss of chromosomes.

Authors: M C Weiss; M Chaplain
Journal: Proc Natl Acad Sci U S A Date: 1971-12 Impact factor: 11.205

8. Xanthine oxidase activity in human tissues and its inhibition by allopurinol (4-hydroxypyrazolo[3,4-d] pyrimidine).

Authors: R W Watts; J E Watts; J E Seegmiller
Journal: J Lab Clin Med Date: 1965-10

9. Studies on cell lines developed from the tissues of patients with galactosemia.

Authors: R S KROOTH; A N WEINBERG
Journal: J Exp Med Date: 1961-06-01 Impact factor: 14.307

10. Establishment of a clonal strain of hepatoma cells which secrete albumin.

Authors: U I Richardson; A H Tashjian; L Levine
Journal: J Cell Biol Date: 1969-01 Impact factor: 10.539

6 in total

Review 1. The clinical pharmacology of 6-mercaptopurine.

Authors: L Lennard
Journal: Eur J Clin Pharmacol Date: 1992 Impact factor: 2.953

Review 2. The use of therapeutic drug monitoring to optimise immunosuppressive therapy.

Authors: S M Tsunoda; F T Aweeka
Journal: Clin Pharmacokinet Date: 1996-02 Impact factor: 6.447

3. A rapid fluorescence technique for electrophoretic identification of hypoxanthine phosphoribosyltransferase allozymes.

Authors: O P Van Diggelen; S Shin
Journal: Biochem Genet Date: 1974-11 Impact factor: 1.890

4. Systematic variations in the content of the purine nucleotides in the steady-state perfused rat heart. Evidence for the existence of controlled storage and release of adenine nucleotides.

Authors: D J Bates; D Perrett; J Mowbray
Journal: Biochem J Date: 1978-11-15 Impact factor: 3.857

Review 5. A re-evaluation of the tissue distribution and physiology of xanthine oxidoreductase.

Authors: A Kooij
Journal: Histochem J Date: 1994-12

6. Clinical and experimental pharmacokinetic interaction between 6-mercaptopurine and methotrexate.

Authors: F Innocenti; R Danesi; A Di Paolo; B Loru; C Favre; M Nardi; G Bocci; D Nardini; P Macchia; M Del Tacca
Journal: Cancer Chemother Pharmacol Date: 1996 Impact factor: 3.333

6 in total